


Ask a doctor about a prescription for PRAMIPEXOL PENSA 0.7 mg TABLETS
Package Leaflet: Information for the User
Pramipexole Pensa 0.7 mg Tablets EFG
Read the entire package leaflet carefully before starting to take this medication,as it contains important information for you.
Contents of the Package Leaflet
Pramipexole Pensa contains the active ingredient pramipexole and belongs to a group of medications called dopaminergic agonists, which stimulate dopamine receptors in the brain. The stimulation of dopaminergic receptors triggers nerve impulses in the brain that help control body movements.
Pramipexole Pensa is used to:
-treat symptoms of idiopathic Parkinson's disease in adults. It can be used alone or in combination with levodopa (another medication for Parkinson's disease).
Do not take Pramipexole Pensa
Warnings and precautions
Consult your doctor before taking Pramipexole Pensa. Inform your doctor if you have or have had any disease or symptom, especially any of the following: - Kidney disease. - Hallucinations (seeing, hearing, or feeling things that are not present). Most hallucinations are visual.
Inform your doctor if you or your family/caregiver notice that you are developing impulses or anxiety to behave in an unusual way and cannot resist the impulse or temptation to carry out certain activities that could harm you or others. Such impulse control disorders may include behaviors such as gambling, compulsive eating or shopping, abnormally increased sexual desire, or increased sexual thoughts. Your doctor may consider adjusting or discontinuing the dose.
Inform your doctor if you, your family, or caregivers notice that you are developing mania (agitation, feeling elated or overexcited) or delirium (decreased consciousness, confusion, loss of contact with reality). Your doctor may need to adjust or discontinue your dose.
Inform your doctor if you notice symptoms such as depression, apathy, anxiety, fatigue, sweating, or pain when stopping or reducing treatment with Pramipexole Pensa. If problems persist for more than a few weeks, your doctor may need to adjust your treatment.
Children and adolescentsPramipexole Pensa is not recommended for use in children or adolescents under 18 years of age.
Using Pramipexole Pensa with other medications
Tell your doctor or pharmacist that you are taking, have recently taken, or may take any other medication. This includes medications, herbal remedies, natural foods, or nutritional supplements that you have obtained without a prescription.
You should avoid using Pramipexole Pensa with antipsychotic medications.
Be cautious if you are using the following medications: - cimetidine (for the treatment of excess acid and stomach ulcers) - amantadine (which may be used in the treatment of Parkinson's disease)
- mexiletine (for the treatment of irregular heartbeats, a condition known as ventricular arrhythmia);
- zidovudine (which may be used to treat acquired immunodeficiency syndrome (AIDS), a disease of the human immune system);
- cisplatin (for the treatment of various types of cancer);
- quinine (which may be used for the prevention of painful leg cramps that occur at night and for the treatment of a type of malaria known as falciparum malaria (malignant malaria));
- procainamide (for the treatment of irregular heartbeat)
If you are using levodopa, it is recommended to decrease the dose of levodopa when starting treatment with Pramipexole Pensa.
Be cautious if you are using sedative medications (with a sedative effect) or if you drink alcohol. In these cases, Pramipexole Pensa may affect your ability to drive and operate machinery.
Taking Pramipexole Pensa with food, drinks, and alcohol
You should be cautious if you drink alcohol during treatment with Pramipexole Pensa. You can take Pramipexole Pensa with or without food.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before taking this medication. Your doctor will indicate whether you should continue treatment with Pramipexole Pensa.
The effect of Pramipexole Pensa on the fetus is not known. Therefore, do not take Pramipexole Pensa if you are pregnant unless your doctor indicates it.
Pramipexole Pensa should not be used during breastfeeding. Pramipexole Pensa may decrease milk production. Additionally, it may pass into breast milk and reach your baby. If the use of Pramipexole Pensa is essential, breastfeeding should be discontinued.
Consult your doctor or pharmacist before using any medication.
Driving and using machines
Pramipexole Pensa may cause hallucinations (seeing, hearing, or feeling things that are not present). If this happens, do not drive or operate machinery.
Pramipexole Pensa has been associated with somnolence and sudden episodes of sleep, especially in patients with Parkinson's disease. If you experience these side effects, do not drive or operate machinery. Inform your doctor if this happens to you.
Follow your doctor's instructions for taking this medication exactly. If you are unsure, consult your doctor again. Your doctor will indicate the correct dosage.
You can take Pramipexole Pensa with or without food. The tablets should be swallowed with water.
Other doses of products containing pramipexole are available for doses that cannot be achieved with this medication.
Parkinson's disease
The daily dose should be taken divided into 3 equal doses.
During the first week, the recommended dose is 1 tablet of pramipexole 0.088 mg three times a day (equivalent to 0.264 mg daily):
1st week | |
Number of tablets | 1 tablet of pramipexole 0.088 mg three times a day |
Daily total dose (mg) | 0.264 |
This dose will be increased every 5-7 days according to your doctor's instructions, until your symptoms are controlled (maintenance dose).
2nd week | 3rd week | |
Number of tablets | 1 tablet of pramipexole 0.18 mg three times a day or 2 tablets of pramipexole 0.088 mg three times a day | 1 tablet of pramipexole 0.35 mg three times a day or 2 tablets of pramipexole 0.18 mg three times a day |
Daily total dose (mg) | 0.54 | 1.1 |
The usual maintenance dose is 1.1 mg per day. However, it may be necessary to increase your dose further. If necessary, your doctor may increase your dose of tablets up to a maximum of 3.3 mg of pramipexole per day. It is also possible to reduce the maintenance dose to three tablets of pramipexole 0.088 mg per day.
Minimum maintenance dose | Maximum maintenance dose | |
Number of tablets | 1 tablet of pramipexole 0.088 mg three times a day | 1 tablet of pramipexole 1.1 mg three times a day |
Daily total dose (mg) | 0.264 | 3.3 |
Patient with kidney disease
If you have moderate or severe kidney disease, your doctor will prescribe a lower dose. In this case, you should take the tablets only once or twice a day. If you have moderate kidney impairment, the usual starting dose is 1 tablet of pramipexole 0.088 mg twice a day. If you have severe kidney impairment, the usual starting dose is 1 tablet of pramipexole 0.088 mg per day.
Restless Legs Syndrome
The dose is usually administered once a day, in the evening, 2-3 hours before bedtime.
During the first week, the usual dose is 1 tablet of pramipexole 0.088 mg once a day (equivalent to 0.088 mg per day):
1st week | |
Number of tablets | 1 tablet of pramipexole 0.088 mg |
Daily total dose (mg) | 0.088 |
This dose will be increased every 4-7 days according to your doctor's instructions, until your symptoms are controlled (maintenance dose).
2nd week | 3rd week | 4th week | |
Number of tablets | 1 tablet of pramipexole 0.18 mg or 2 tablets of pramipexole 0.088 mg | 1 tablet of pramipexole 0.35 mg or 2 tablets of pramipexole 0.18 mg or 4 tablets of pramipexole 0.088 mg | 1 tablet of pramipexole 0.35 mg and 1 tablet of pramipexole 0.18 mg or 3 tablets of pramipexole 0.18 mg or 6 tablets of pramipexole 0.088 mg |
Daily total dose (mg) | 0.18 | 0.35 | 0.54 |
The daily dose for the treatment of Restless Legs Syndrome should not exceed 6 tablets of pramipexole 0.088 mg or a dose of 0.54 mg (0.75 mg of pramipexole salt).
If you stop taking your tablets for a few days and want to resume treatment, you should start again with the smallest dose and then gradually increase the dose as you did the first time. Consult your doctor if you have any doubts.
Your doctor will evaluate your treatment after 3 months to decide whether to continue or not with the treatment.
Patient with kidney disease:
If you have severe kidney disease, pramipexole pensa may not be a suitable treatment for your Restless Legs Syndrome.
If you take more Pramipexole Pensa than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
-you may experience vomiting, restlessness, or any of the side effects described in section 4.
If you forget to take Pramipexole Pensa
Do not worry. Omit that dose completely and take the next dose at the correct time. Do not take a double dose to make up for forgotten doses.
If you stop taking Pramipexole Pensa
Do not stop your treatment with pramipexole without consulting your doctor first. If you need to stop your treatment with this medication, your doctor will gradually reduce your dose. This reduces the risk of worsening symptoms.
If you have Parkinson's disease, you should not stop your treatment with pramipexole abruptly. Sudden interruption can cause the appearance of a disorder called neuroleptic malignant syndrome, which can be a very serious risk to your health. These symptoms include:
If you stop or reduce the dose of pramipexole, you may also suffer from a medical disorder called dopamine agonist withdrawal syndrome. The symptoms include depression, apathy, anxiety, fatigue, sweating, or pain. If you experience these symptoms, you should contact your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Pramipexol Pensa can cause adverse effects, although not all people suffer from them. The classification of adverse effects is based on the following frequencies:
Very Frequent:May affect more than 1 in 10 people |
Frequent:May affect up to 1 in 10 people |
Infrequent:May affect up to 1 in 100 people |
Rare:May affect up to 1 in 1,000 people |
Very Rare:May affect up to 1 in 10,000 people |
Unknown:Frequency cannot be estimated from available data |
If you have Parkinson's disease, you may experience the following adverse effects:
Very Frequent:
-Dyskinesia (e.g., abnormal involuntary movements of the limbs)
-Dizziness
-Nausea
Frequent:
-Need to behave in an unusual way
-Hallucinations (seeing, hearing, or feeling things that are not present)
-Confusion
-Fatigue
-Excess fluid, usually in the legs (peripheral edema)
-Headache
-Hypotension (low blood pressure)
-Abnormal dreams
-Constipation
-Vomiting (nausea)
-Weight loss, including loss of appetite
Infrequent:-Paranoia (e.g., excessive concern for one's health)-Delirium-Excessive daytime somnolence and sudden sleep episodes
-Amnesia (memory impairment)-Hyperkinesia (increased movement and inability to remain still)-Weight gain-Allergic reactions (e.g., skin rash, itching, hypersensitivity)
-Fainting
-Heart failure (heart problems that can cause shortness of breath or swelling of the ankles)*
-Inappropriate secretion of antidiuretic hormone*
-Restlessness
-Dyspnea (difficulty breathing)
-Hiccup
-Pneumonia (lung infection)
Rare:
Unknown Frequency:
After stopping or reducing treatment with Pramipexol Pensa: depression, apathy, anxiety, fatigue, sweating, or pain (known as dopamine agonist withdrawal syndrome or DAWS) may occur.
Inform your doctor if you experience any of these behaviors; they will decide on ways to control or reduce the symptoms
For the adverse effects marked with *, it is not possible to provide a precise estimate of the frequency, as these adverse effects were not observed in clinical trials in 2,762 patients treated with pramipexol. The frequency category is likely not higher than "infrequent".
If you have Restless Legs Syndrome, you may experience the following adverse effects:
Very Frequent:
Frequent:
Infrequent:
Unknown Frequency:
-After stopping or reducing treatment with Pramipexol Pensa: depression, apathy, anxiety, fatigue, sweating, or pain (known as dopamine agonist withdrawal syndrome or DAWS) may occur.
Inform your doctor if you experience any of these behaviors; they will explain how to manage or reduce the symptoms.
For the adverse effects marked with *, it is not possible to provide a precise estimate of the frequency, as these adverse effects were not observed in clinical trials in 1,395 patients treated with pramipexol. The frequency category is likely not higher than "infrequent".
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children. Do not take this medicine after the expiration date that appears on the packaging and on the blister after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from light. This medicine does not require special storage conditions
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Pramipexol Pensa
The active ingredient is pramipexol.
Each tablet contains 0.7 mg of pramipexol base.
The other components are: mannitol, cornstarch, hydroxypropylcellulose, colloidal anhydrous silica, magnesium stearate.
Appearance of the Product and Packaging Content
Pramipexol Pensa 0.7 mg tablets: white, round, flat tablets, scored on one side (diameter: approximately 9 mm).
The tablet can be divided into two equal halves.
It is presented in OPA/aluminum/PVC/aluminum blister strips of 10 tablets per strip, in boxes containing 3 or 10 blister strips.
Packaging of 30 tablets, 100 tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles, Barcelona
Spain
Manufacturer
PharmaPath S.A.
28is Oktovriou 1,
Agia Varvara, 123 51
Greece
This medicine is authorized in the EEA Member States with the following names:
IT: Pramipexolo Pensa 0.7 mg compresse.
ES: Pramipexol pensa 0.7 mg comprimidos EFG
Date of the Last Revision of this Prospectus:December 2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for PRAMIPEXOL PENSA 0.7 mg TABLETS – subject to medical assessment and local rules.